Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor B Resnick

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Clinical Transplantation|November 30, 2005
Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimenIgor B Resnick, Ali Abdul Hai, Michael Y Shapira, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patientsIgor B Resnick, Panagiotis D Tsirigotis, Michael Y Shapira, et al.
Haematologica|November 27, 2010
IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approachPolina Stepensky, Michael Weintraub, Asaf Yanir, et al.
Antiviral Research|March 30, 2011
Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantationDana G Wolf, Avichai Shimoni, Igor B Resnick, et al.
Immunotherapy|July 20, 2010
Post-hematopoietic stem cell transplantion immune-mediated cytopeniasPanagiotis D Tsirigotis, Igor B Resnick, Reuven Or, et al.
American Journal of Medical Genetics. Part A|July 2, 2003
657del5 mutation in the gene for Nijmegen breakage syndrome (NBS1) in a cohort of Russian children with lymphoid tissue malignancies and controlsIgor B Resnick, Irina Kondratenko, Eugeni Pashanov, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2004
Early-onset Guillain-Barré syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantationMenachem Bitan, Reuven Or, Michael Y Shapira, et al.
Immunotherapy|May 13, 2014
Irradiated mononuclear cells express significant in vitro cytotoxic activity: promise for in vivo clinical efficacy of irradiated mismatched donor lymphocytes infusionPanagiotis Tsirigotis, Igor B Resnick, Violetta Kapsimalli, et al.
Haematologica|June 14, 2006
A non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in elderly patientsPanagiotis Tsirigotis, Reuven OrMenachem Bitan, Igor B Resnick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantationMichael Y Shapira, Igor B Resnick, Sunwen Chou, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Clinical Transplantation|November 30, 2005
Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimenIgor B Resnick, Ali Abdul Hai, Michael Y Shapira, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patientsIgor B Resnick, Panagiotis D Tsirigotis, Michael Y Shapira, et al.
Haematologica|November 27, 2010
IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approachPolina Stepensky, Michael Weintraub, Asaf Yanir, et al.
Antiviral Research|March 30, 2011
Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantationDana G Wolf, Avichai Shimoni, Igor B Resnick, et al.
Immunotherapy|July 20, 2010
Post-hematopoietic stem cell transplantion immune-mediated cytopeniasPanagiotis D Tsirigotis, Igor B Resnick, Reuven Or, et al.
American Journal of Medical Genetics. Part A|July 2, 2003
657del5 mutation in the gene for Nijmegen breakage syndrome (NBS1) in a cohort of Russian children with lymphoid tissue malignancies and controlsIgor B Resnick, Irina Kondratenko, Eugeni Pashanov, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2004
Early-onset Guillain-Barré syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantationMenachem Bitan, Reuven Or, Michael Y Shapira, et al.
Immunotherapy|May 13, 2014
Irradiated mononuclear cells express significant in vitro cytotoxic activity: promise for in vivo clinical efficacy of irradiated mismatched donor lymphocytes infusionPanagiotis Tsirigotis, Igor B Resnick, Violetta Kapsimalli, et al.
Haematologica|June 14, 2006
A non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in elderly patientsPanagiotis Tsirigotis, Reuven OrMenachem Bitan, Igor B Resnick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantationMichael Y Shapira, Igor B Resnick, Sunwen Chou, et al.
Pageof 5